Study period | ||||||
---|---|---|---|---|---|---|
allocation | post allocation | |||||
Study visit number | 1 | 1 | 2 | 3 | 4 | 5 |
Age (months) | 1 | 1 | 2 | 4 | 6 | 7 |
Eligibility screen | x | |||||
Informed consent signed | x | |||||
Randomisation | x | |||||
Interventions – Pneumococcal conjugate vaccines | ||||||
Prevenar13 (_PPP) | _ | P | P | P | ||
Synflorix (_SSS) | _ | S | S | S | ||
COMBO (SSSP) | S | S | S | P | ||
RotarixR | x | x | ||||
InfanrixR Hexa | x | x | x | |||
Outcome assessments | ||||||
Risk factor data and interviews | ||||||
Fixed e.g. sex, birthweight, gestational age, maternal education | x | |||||
Not fixed e.g. household occupancy, smoke exposure, breastfeeding | x | x | ||||
Blood draw (heel, finger prick, or venepuncture) | x* | x* | x | |||
Ear assessment | ||||||
Tympanometry | x | x | x | x | x | |
Video otoscopy | x | x | x | |||
Nasopharyngeal swab | x§ | x | x | x | x | |
General health (skin, chest, nose, temp, weight, length) and medical record review | x | x | x | x | x |